These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 22160229)
21. Subjective experiences during dopamine depletion. de Haan L; Booij J; Lavalye J; van Amelsvoort T; Linszen D Am J Psychiatry; 2005 Sep; 162(9):1755. PubMed ID: 16135643 [No Abstract] [Full Text] [Related]
22. Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder. Denys D; van der Wee N; Janssen J; De Geus F; Westenberg HG Biol Psychiatry; 2004 May; 55(10):1041-5. PubMed ID: 15121489 [TBL] [Abstract][Full Text] [Related]
23. Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes. Hierholzer J; Cordes M; Venz S; Schelosky L; Harisch C; Richter W; Keske U; Hosten N; Mäurer J; Poewe W; Felix R J Nucl Med; 1998 Jun; 39(6):954-60. PubMed ID: 9627325 [TBL] [Abstract][Full Text] [Related]
24. [99mTc]TRODAT-1/[123I]IBZM SPECT studies of the dopaminergic system in Tourette syndrome. Hwang WJ; Yao WJ; Fu YK; Yang AS Psychiatry Res; 2008 Feb; 162(2):159-66. PubMed ID: 18248965 [TBL] [Abstract][Full Text] [Related]
25. Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans. Cropley VL; Innis RB; Nathan PJ; Brown AK; Sangare JL; Lerner A; Ryu YH; Sprague KE; Pike VW; Fujita M Synapse; 2008 Jun; 62(6):399-408. PubMed ID: 18361438 [TBL] [Abstract][Full Text] [Related]
26. Comparison of gastric relaxation and sensory functions between functional dyspepsia and healthy subjects using novel drinking-ultrasonography test. Hata T; Kato M; Kudo T; Nishida M; Nishida U; Imai A; Yoshida T; Hirota J; Kamada G; Ono S; Nakagawa M; Nakagawa S; Shimizu Y; Takeda H; Asaka M Digestion; 2013; 87(1):34-9. PubMed ID: 23343967 [TBL] [Abstract][Full Text] [Related]
27. Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Abi-Dargham A; Kegeles LS; Zea-Ponce Y; Mawlawi O; Martinez D; Mitropoulou V; O'Flynn K; Koenigsberg HW; Van Heertum R; Cooper T; Laruelle M; Siever LJ Biol Psychiatry; 2004 May; 55(10):1001-6. PubMed ID: 15121484 [TBL] [Abstract][Full Text] [Related]
28. Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study. Braak B; Klooker TK; Wouters MM; Lei A; van den Wijngaard RM; Boeckxstaens GE Aliment Pharmacol Ther; 2011 Sep; 34(6):638-48. PubMed ID: 21767283 [TBL] [Abstract][Full Text] [Related]
29. The proximal stomach and postprandial symptoms in functional dyspeptics. Boeckxstaens GE; Hirsch DP; Kuiken SD; Heisterkamp SH; Tytgat GN Am J Gastroenterol; 2002 Jan; 97(1):40-8. PubMed ID: 11811168 [TBL] [Abstract][Full Text] [Related]
30. No effect of dopamine depletion on the binding of the high-affinity D 2/3 radiotracer [11C]FLB 457 in the human cortex. Frankle WG; Mason NS; Rabiner EA; Ridler K; May MA; Asmonga D; Chen CM; Kendro S; Cooper TB; Mathis CA; Narendran R Synapse; 2010 Dec; 64(12):879-85. PubMed ID: 20506387 [TBL] [Abstract][Full Text] [Related]
31. Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: an in vivo SPECT study. Safont G; Corripio I; Escartí MJ; Portella MJ; Pérez V; Ferrer M; Camacho V; Sauras RB; Alonso A; Grasa EM; Arranz B; San L; Dueñas R; Carrió I; Álvarez E Schizophr Res; 2011 Jul; 129(2-3):169-71. PubMed ID: 21459559 [TBL] [Abstract][Full Text] [Related]
32. A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects. Verhoeff NP; Kapur S; Hussey D; Lee M; Christensen B; C Psych ; Papatheodorou G; Zipursky RB Neuropsychopharmacology; 2001 Aug; 25(2):213-23. PubMed ID: 11425505 [TBL] [Abstract][Full Text] [Related]
33. Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia. Lacy BE; Saito YA; Camilleri M; Bouras E; DiBaise JK; Herrick LM; Szarka LA; Tilkes K; Zinsmeister AR; Talley NJ Am J Gastroenterol; 2018 Feb; 113(2):216-224. PubMed ID: 29257140 [TBL] [Abstract][Full Text] [Related]
34. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease. Ichise M; Toyama H; Fornazzari L; Ballinger JR; Kirsh JC J Nucl Med; 1993 Aug; 34(8):1274-81. PubMed ID: 8326384 [TBL] [Abstract][Full Text] [Related]
35. In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand. de Herder WW; Reijs AE; Kwekkeboom DJ; Hofland LJ; Nobels FR; Oei HY; Krenning EP; Lamberts SW Clin Endocrinol (Oxf); 1996 Dec; 45(6):755-67. PubMed ID: 9039343 [TBL] [Abstract][Full Text] [Related]
36. Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPECT study using 123I-beta-CIT and 123I-IBZM. Donnemiller E; Brenneis C; Wissel J; Scherfler C; Poewe W; Riccabona G; Wenning GK Eur J Nucl Med; 2000 Sep; 27(9):1410-4. PubMed ID: 11007526 [TBL] [Abstract][Full Text] [Related]